Filters: keyword is Double-Blind Method [Clear All Filters]
- 2008
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy,
J Psychiatr Res, vol. 42, no. 12, pp. 1000-9.
- 2007
Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers,
Clin Pharmacol Ther, vol. 81, no. 1, pp. 50-8.
- 2006
A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus,
J Pharmacokinet Pharmacodyn, vol. 33, no. 3, pp. 313-43.
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers,
Anesthesiology, vol. 104, no. 6, pp. 1232-42.
Naloxone reversal of buprenorphine-induced respiratory depression,
Anesthesiology, vol. 105, no. 1, pp. 51-7.
- 2005
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats,
Br J Anaesth, vol. 94, no. 6, pp. 825-34.
- 2000
Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery,
Eur J Clin Pharmacol, vol. 56, no. 1, pp. 89-95.
- 1999
Pilot study in humans on the pharmacokinetics and safety of propofol 6% SAZN,
Pharm World Sci, vol. 21, no. 5, pp. 239-40.
Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection,
Br J Clin Pharmacol, vol. 47, no. 6, pp. 653-60.
- 1997
Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates,
Br J Clin Pharmacol, vol. 43, no. 6, pp. 603-12.
Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations,
Eur J Clin Pharmacol, vol. 53, no. 1, pp. 57-63.
- 1992
Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers,
Clin Pharmacol Ther, vol. 51, no. 6, pp. 715-28.
Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects,
Eur J Clin Pharmacol, vol. 42, no. 3, pp. 319-24.
- 1991
Pharmacokinetics and EEG effects of flumazenil in volunteers,
Clin Pharmacokinet, vol. 20, no. 6, pp. 491-6.



